PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Results of the first prototypical Ring Trial of QuIP for PD-L1 Expression in Urothelial Carcinomas (2020) Sommer U, Baretton G, Hartmann A, Eckstein M, Schwamborn K, Weichert W, Kristiansen G, et al. Journal article, Editorial Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy (2020) Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz R, Pfannstiel C, Wullweber A, et al. Journal article CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage (2020) Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, et al. Journal article Collective forces of tumor spheroids in three-dimensional biopolymer networks (2020) Mark C, Grundy TJ, Strissel P, Böhringer D, Grummel N, Gerum R, Steinwachs J, et al. Journal article FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy (2020) Sikic D, Eckstein M, Wirtz RM, Jarczyk J, Worst TS, Porubsky S, Keck B, et al. Journal article Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation (2020) Morsch R, Rose M, Maurer A, Cassataro MA, Braunschweig T, Knüchel R, Vögeli TA, et al. Journal article Pure large nested variant of urothelial carcinoma (Lnuc) is the prototype of an fgfr3 mutated aggressive urothelial carcinoma with luminal-papillary phenotype (2020) Weyerer V, Eckstein M, Compérat E, Juette H, Gaisa NT, Allory Y, Stöhr R, et al. Journal article Evaluation of Potential Targeted Therapy and Molecular Subtype in Large Nested Variant of Urothelial Carcinoma (LNUC) (2020) Weyerer V, Eckstein M, Comperat E, Juette H, Gaisa N, Allory Y, Stoehr R, et al. Conference contribution Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view (2020) Cimadamore A, Scarpelli M, Massari F, Eckstein M, Gevaert T, Cheng L, Lopez-Beltran A, Montironi R Journal article, Editorial Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data (2020) Kim WY, Rose T, Roghmann F, Eckstein M, Jarczyk J, Zengerling F, Sikic D, et al. Conference contribution